High Dose PPI + Aspirin in Barrett’s Esophagus
Esophageal carcinoma is the 6th most common cause of cancer with Barrett’s esophagus contributing to be the biggest risk factor. A randomized trial performed studied role of high-dose PPI and aspirin for improving outcomes in patients with Barrett’s esophagus. Patients with 1 cm or more of Barrett’s esophagus at 84 different centers in UK and Canada were randomized 1:1:1:1 using a computerized schedule to receive high-dose ( 40 mg ...
Continue reading